Oxidative testicular injury: effect of L-leucine on redox, cholinergic and purinergic dysfunctions, and dysregulated metabolic pathways

Amino Acids. 2021 Mar;53(3):359-380. doi: 10.1007/s00726-021-02954-4. Epub 2021 Feb 14.

Abstract

The antioxidant and anti-proinflammatory activities of L-leucine were investigated on oxidative testicular injury, ex vivo. In vitro analysis revealed L-leucine to be a potent scavenger of free radicals, while inhibiting acetylcholinesterase activity. Oxidative injury was induced in testicular tissues using FeSO4. Treatment with L-leucine led to depletion of oxidative-induced elevated levels of NO, MDA, and myeloperoxidase activity, with concomitant elevation of reduced glutathione and non-protein thiol levels, SOD and catalase activities. L-leucine caused a significant (p < 0.05) alteration of oxidative-elevated acetylcholinesterase and chymotrypsin activities, while concomitantly elevating the activities of ATPase, ENTPDase and 5'-nucleotidase. L-leucine conferred a protective effect against oxidative induced DNA damage. Molecular docking revealed molecular interactions with COX-2, IL-1 beta and iNOS. Treatment with L-leucine led to restoration of oxidative depleted ascorbic acid-2-sulfate, with concomitant depletion of the oxidative induced metabolites: D-4-Hydroxy-2-oxoglutarate, L-cystine, adenosine triphosphate, maleylacetoacetic acid, cholesteryl ester, and 6-Hydroxy flavin adenine dinucleotide. Treatment with L-leucine reactivated glycolysis while concomitantly deactivating oxidative-induced citrate cycle and increasing the impact-fold of purine metabolism pathway. L-leucine was predicted not to be an inhibitor of CYP1A2, CYP2C19, CYP2C9, CYP2D6, and CYP3A4, with a predicted LD50 value of 5000 mg/Kg and toxicity class of 5. Additionally, L-leucine showed little or no in vitro cytotoxicity in mammalian cells. These results suggest the therapeutic potentials of L-leucine on oxidative testicular injury, as evident by its ability to attenuate oxidative stress and proinflammation, while stalling cholinergic dysfunction and modulating nucleotide hyrolysis; as well as modulate oxidative dysregulated metabolites and their pathways.

Keywords: Amino acids; Antioxidants; L-leucine; Medicinal biochemistry; Proinflammation; Testicular dysfunction.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / metabolism
  • Antioxidants / metabolism
  • Cell Line
  • Cell Survival / drug effects
  • Cholinergic Agents / chemistry
  • Cholinergic Agents / metabolism*
  • DNA Damage / drug effects
  • Ferrous Compounds / toxicity
  • Humans
  • Leucine / chemistry
  • Leucine / pharmacology*
  • Male
  • Metabolic Networks and Pathways / drug effects*
  • Molecular Docking Simulation
  • Oxidative Stress / drug effects*
  • Purinergic Agents / metabolism*
  • Rats
  • Testis / injuries*
  • Testis / metabolism

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • Cholinergic Agents
  • Ferrous Compounds
  • Purinergic Agents
  • ferrous sulfate
  • Leucine